Anavex's Blarcamesine: Why It May Treat Alzheimer's Disease (NASDAQ:AVXL)
seekingalpha.com
finance
2022-06-02 23:28:36

ollaweila/iStock via Getty Images The manner in which Anavex Life Sciences Corp.'s (NASDAQ:AVXL) blarcamesine fits into the following quote and chart helps explain why it should help treat Alzheimer's disease: The inflammatory mediator peroxynitrite, when generated in excess, may damage cells by oxidizing and nitrating cellular components. Defense against this reactive species may be at the level of prevention of the formation of peroxynitrite, at the level of interception, or at the level of repair of damage caused by peroxynitrite (source of quote).
